| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.5M | +150.0% | — |
| R&D Expense | $3.8M | -58.2% | -41.2% |
| SG&A Expense | $27.6M | +115.7% | +324.9% |
| Operating Income | -$18.9M | -12.0% | -45.9% |
| Pre-tax Income | -$16.7M | -15.9% | -63.5% |
| Income Tax | $0 | -100.0% | — |
| Net Income | -$16.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.4M | -32.5% | -38.1% |
| Inventory | $949K | — | — |
| Current Assets | $207.0M | -3.1% | -6.2% |
| Total Assets | $210.7M | -3.0% | -5.9% |
| Current Liabilities | $16.3M | +56.9% | +111.6% |
| Total Liabilities | $16.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$36.1M | — | — |
| Capital Expenditures | $789K | — | — |
| Investing Cash Flow | $14.1M | — | — |
| Financing Cash Flow | $27.1M | — | — |
| Free Cash Flow | -$36.9M | — | — |
| -63.5% |
| EPS (Basic) | -$0.59 | -11.3% | -55.3% |
| EPS (Diluted) | -$0.59 | -11.3% | -55.3% |
| +53.0% |
| +92.2% |
| Stockholders' Equity | $193.9M | -6.0% | -9.9% |